Enfagrow Premium Toddler Transitions
Allegations: Deceptively marketing products as “nutritionally appropriate” for children between nine and eighteen months
Enfamil Baby Formula Powders
Case Name (Date)
Wacker et al. v. Mead Johnson & Co., LLC
22PH-CV-00808, Missouri state court – Phelps County
(June 2022)
Product/Service
Enfamil baby formula powders
Allegations
Products do not contain enough powder to make the advertised number of bottles
Status
Settled
(Final approval granted)
http://www.mjcservingsettlement.com/
Class-Action Tracker
Enfamil and Enfamil Premature
Allegations: Falsely marketing products as safe when they are dangerous for premature infants
Enfamil Infant Formula
Allegations: Failing to disclose that products contain toxic heavy metals
Enfamil Infant Formulas
Allegations: Misleadingly marketing infant formulas as “Milk-based” when the primary ingredient is a form of sugar
The Latest
CATrends: OTC Cold and Flu Meds Falsely Marketed as Nasal Decongestants
An FDA panel’s recent findings has led to a flood of lawsuits.
Researchers Call on FDA (Again) to Remove ‘Ineffective’ OTC Cold and Flu Medicines
Products marketed to clear up stuffy noses and relieve sinus congestion don’t work, researchers say.
Proposed Settlement Allows for Continued Deceptive Marketing of Neuriva
TINA.org files brief urging court to deny final approval of settlement that is unfair to consumers.
CATrends: Toddler Formula
It’s the perfect formula for a class-action lawsuit trend.
